Rankings
▼
Calendar
AQST FY 2017 Earnings — Aquestive Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
AQST
Aquestive Therapeutics, Inc.
$427M
FY 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$67M
+29.2% YoY
Gross Profit
$47M
70.4% margin
Operating Income
-$113,000
-0.2% margin
Net Income
-$9M
-13.4% margin
EPS (Diluted)
$-0.45
Cash Flow
Operating Cash Flow
$6M
Free Cash Flow
$4M
Stock-Based Comp.
$0
Balance Sheet
Total Assets
$43M
Total Liabilities
$70M
Stockholders' Equity
-$26M
Cash & Equivalents
$17M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$67M
$52M
+29.2%
Gross Profit
$47M
$35M
+33.0%
Operating Income
-$113,000
-$847,000
+86.7%
Net Income
-$9M
-$10M
+6.9%
← FY 2016
All Quarters
Q1 2017 →